Nodular thyroid disease medical therapy
Jump to navigation
Jump to search
|
Nodular thyroid disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nodular thyroid disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Nodular thyroid disease medical therapy |
|
Risk calculators and risk factors for Nodular thyroid disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
- Radioiodine (I-131) is as effective as surgery for the treatment of toxic multinodular goiter, however has a more prolonged reversal of hyperthyroidism after therapy. It has also been used for the treatment of non-toxic multinodular goiter.
- Antithyroid drugs, such as propylthiouracil (PTU) or methimazole are not 1st line agents in treating nodular thyroid disease when overt hyperthyroidism is present. This is primarily due to the fact that this treatment would be lifelong. These drugs are mainly used prior to surgery, as they have been shown to lower the operative risk. Additionally, when given prior to radioiodine therapy, they have been shown to achieve a state of euthyroidism more rapidly, and decrease the exacerbations of hyperthyroidism.
- Recent studies, however, report no significant difference between thyroxine and placebo for the treatment of benign nodules.
- If a nodule grows, with or without replacement, surgery is indicated.
References